Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
Biorxiv : the Preprint Server for Biology|April 1, 2025
Functional and structural profiling of circulation via genetically encoded modular fluorescent probesMarta Vittani, Ashley Bomin Lee, Xiaowen Wang, et al.
Neuropsychopharmacology Reports|July 14, 2026
Association Between Participant Satisfaction and Self-Reported Clinical Practice Behaviors in a Nationwide Guideline Education ProgramKazuhiko Yamamuro, Kenta Ide, Yusuke Arai, et al.
Nature Communications|June 19, 2021
Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorderMasaki Nishioka, An-A Kazuno, Takumi Nakamura, et al.
BMC Psychiatry|October 9, 2025
Maintenance pharmacotherapy after electroconvulsive therapy in inpatients with major depressive disorder: 198 prescriptions in a real-world clinical settingShun Igarashi, Takashi Tsuboi, Naomi Hasegawa, et al.
The International Journal of Neuropsychopharmacology|March 28, 2025
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide studyShinichiro Ochi, Fumitoshi Kodaka, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|December 2, 2021
Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation studyNorio Yasui-Furukori, Hiroyuki Muraoka, Naomi Hasegawa, et al.
Neuropsychopharmacology Reports|March 11, 2021
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation studyShusuke Numata, Masahito Nakataki, Naomi Hasegawa, et al.
Asian Journal of Psychiatry|July 29, 2021
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment projectNaoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, et al.
BMC Psychiatry|May 28, 2024
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter studyToshinori Nakamura, Ryuji Furihata, Naomi Hasegawa, et al.
Sleep Medicine|December 7, 2021
Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide studyRyuji Furihata, Rei Otsuki, Naomi Hasegawa, et al.
Pageof 25